(S)-N-methyl-N-((5-(methyl(1-methylpiperidin-4-yl)amino)imidazo[1,2-a]pyridin-2-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine

ID: ALA570968

PubChem CID: 11596908

Max Phase: Preclinical

Molecular Formula: C25H34N6

Molecular Weight: 418.59

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCC(N(C)c2cccc3nc(CN(C)[C@H]4CCCc5cccnc54)cn23)CC1

Standard InChI:  InChI=1S/C25H34N6/c1-28-15-12-21(13-16-28)30(3)24-11-5-10-23-27-20(18-31(23)24)17-29(2)22-9-4-7-19-8-6-14-26-25(19)22/h5-6,8,10-11,14,18,21-22H,4,7,9,12-13,15-17H2,1-3H3/t22-/m0/s1

Standard InChI Key:  IJRADFNTAYCYKO-QFIPXVFZSA-N

Molfile:  

     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   15.8815   -7.5911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3855   -8.2435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3462   -6.9101    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3126   -5.5177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3114   -6.3447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0259   -6.7573    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.0241   -5.1052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7390   -5.5141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7378   -6.3467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4543   -6.7617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1766   -6.3488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1778   -5.5161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4567   -5.0966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4520   -7.5863    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.1649   -8.0006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1376   -7.1415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1587   -7.9647    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.8809   -8.3562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5825   -7.9256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5573   -7.0996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8346   -6.7118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7368   -7.9966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9031   -9.1804    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2003   -9.6117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6279   -9.5734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4766   -9.2153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7758   -9.6429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7937  -10.4677    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5185  -10.8629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2254  -10.4333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0893  -10.8963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 16  3  2  0
 14 15  1  0
 15  1  1  0
  8  7  2  0
  7  4  1  0
 16 17  1  0
  8  9  1  0
 17 18  1  0
  3  1  1  0
 18 19  2  0
  1  2  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
  4  5  2  0
 14 22  1  0
  2 17  1  0
 18 23  1  0
  5  6  1  0
 23 24  1  0
  8 13  1  0
 23 25  1  0
 24 26  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  6  9  2  0
 24 30  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 10 14  1  6
 28 31  1  0
M  END

Associated Targets(Human)

HOS (906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CXCR4 Tclin C-X-C chemokine receptor type 4 (3338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 418.59Molecular Weight (Monoisotopic): 418.2845AlogP: 3.77#Rotatable Bonds: 5
Polar Surface Area: 39.91Molecular Species: BASEHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.73CX LogP: 2.74CX LogD: 1.29
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.63Np Likeness Score: -1.38

References

1. Gudmundsson KS, Boggs SD, Catalano JG, Svolto A, Spaltenstein A, Thomson M, Wheelan P, Jenkinson S..  (2009)  Imidazopyridine-5,6,7,8-tetrahydro-8-quinolinamine derivatives with potent activity against HIV-1.,  19  (22): [PMID:19818609] [10.1016/j.bmcl.2009.09.056]

Source